+
Adams
PC, Barton
JC. Hemochromatosis. Lancet. 2007;370:1855–60.
+
Adams
PC, Reboussin
DM, Barton
JC
et al.. Hemochromatosis and iron overload screening in a racially diverse population (HEIRS study). N Engl J Med. 2005;352:1769–78.
+
Afdhal
NH. Management of nonalcoholic fatty liver disease. JAMA. 2012;308:608–16.
+
American Gastroenterological Association. Evaluation of liver chemistry tests. Gastroenterology. 2002;123:1364–66.
+
Barkun
AN, Grover
SA, Muir
A. Update: splenomegaly. In: Simel
DL, Rennie
D, eds. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. New York, NY: McGraw-Hill; 2009.
+
Brundage
SC, Fitzpatrick
AN. Hepatitis A. Am Fam Physician. 2006;73:2162–8.
+
Chalasani
N, Younossi
Z, Lavine
JE
et al.. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–23.
+
Forrest
EH. The management of alcoholic hepatitis. Br J Hosp Med. 2009;70:680–4.
+
Ghany
MG, Strader
DB, Thomas
DL, Seeff
LB. Diagnosis, management and treatment of hepatitis C: an update. Hepatology. 2009;49:1335.
+
Giannini
EG, Testa
R, Savarino
V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172:367–79.
+
Hennes
EM, Zeniya
M, Czaja
AJ
et al.. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.
+
Hung
OL, Kwon
NS, Cole
AE
et al.. Evaluation of the physician’s ability to recognize the presence or absence of anemia, fever, and jaundice. Acad Emerg Med. 2000;7:146–56.
+
Kuo
A, Gish
R. Chronic hepatitis B infection. Clin Liv Dis. 2012;16:347–69.
+
Liaw
YF, Chu
CM. Hepatitis B infection. Lancet. 2009;373:582–92.
+
Maheshwari
A, Ray
S, Thuluvath
PJ. Acute hepatitis C. Lancet. 2008;372:321–32.
+
McGee
S. Evidence-Based Physical Diagnosis, 3rd edition. Saunders. 2012.
+
Musso
G, Gambino
R, Cassader
M, Pagano
G. Meta-analysis: natural history of nonalcoholic fatty liver disease and diagnostic accuracy on noninvasive tests for liver disease severity. Ann Med. 2011;43:617–49.
+
O'Shea
RS, Dasarathy
S, McCullough
AJ. Alcoholic liver disease: ACG Practice Guidelines. Am J Gastroenterol. 2010;105:14–32.
+
Porta
M, Fabregat
X, Malats
N
et al.. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 2005;7:189–97.
+
Rosen
HR. Chronic hepatitis C infection. N Engl J Med. 2011;364:2429–38.
+
Sass
DA, Shaikh
OS. Alcoholic hepatitis. Clin Liver Dis. 2006;10:219–37.
+
Schaefer
E, Pratt
DS. Autoimmune hepatitis: current challenges in diagnosis and management in a chronic progressive liver disease. Curr Opin Rheumatol. 2012;24:84–9.
+
Simel
DL, Hatala
R, Edelman
D. Update: ascites. In: Simel
DL, Rennie
D, eds. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. New York, NY: McGraw-Hill; 2009.
+
Simel
DL, D'Silva
M. Update: hepatomegaly. In: Simel
DL, Rennie
D, eds. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. New York, NY: McGraw-Hill; 2009.
+
van Bokhoven
MA, van Deursen
C, Swinkels
DW. Diagnosis and management of hereditary haemochromatosis. BMJ. 2011;342:c7251.
+
Vincent
A, Herman
J, Schulick
R
et al.. Pancreatic cancer. Lancet. 2011;378:607–20.
+
Wilkins
T, Malcolm
J, Raina
D, Schade
RR. Hepatitis C: diagnosis and treatment. Am Fam Physician. 2010;81:1351–7.